These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4990295)

  • 1. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

  • 2. AO44: an improved hyperglycemic agent.
    Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
    Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G
    Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between diphenylhydantoin and tolbutamide in mice.
    Mennear JH; Gossel TA
    Toxicol Appl Pharmacol; 1973 Feb; 24(2):309-16. PubMed ID: 4696312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of insulin-secretion, induced by glucose, of the isolation-perfused rat pancreas using tolbutamide, glucosamine, diazoxide, glucagon and endogenous insulin].
    Bierwolf B; Blech W
    Acta Biol Med Ger; 1976; 35(5):583-95. PubMed ID: 983609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
    Seltzer HS; Crout JR
    Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 10. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
    Mariani MM
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of diazoxide hyperglycemia in animals.
    Tabachnick II; Gulbenkian A
    Ann N Y Acad Sci; 1968 Apr; 150(2):204-18. PubMed ID: 4299216
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of diazoxide effects by tolbutamide.
    Wales JK; Grant AM; Wolff FW
    Lancet; 1967 May; 1(7500):1137-8. PubMed ID: 4164793
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diazoxide: mechanism of its hyperglycemic action and therapeutic possibilities].
    Brunetti P; Santeusanio F
    Acta Diabetol Lat; 1969; 6(4):844-55. PubMed ID: 4395392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypoglycemic action of certain heterocyclic carboxylic acid derivatives].
    Takasaki K; Kaneko M; Fujii T; Kobayashi H
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):977-94. PubMed ID: 4799525
    [No Abstract]   [Full Text] [Related]  

  • 16. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
    Basabe JC; Lopez NL; Viktora JK; Wolff FW
    Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats].
    Losert W; Loge O; Jahn P
    Arzneimittelforschung; 1973 Sep; 23(9):1251-60. PubMed ID: 4149442
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.
    Loubatières-Mariani MM; Loubatières AL; Chapal J
    Diabetologia; 1973 Apr; 9(2):152-7. PubMed ID: 4716116
    [No Abstract]   [Full Text] [Related]  

  • 20. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.